Functional analysis of four LDLR 5′UTR and promoter variants in patients with familial hypercholesterolaemia

Marks D, Thorogood M, Neil HA, Humphries SE : A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 2003; 168: 1–14.

Nordestgaard BG, Chapman MJ, Humphries SE et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013; 34: 3478–90a.

Soutar AK, Naoumova RP : Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nature clinical practice. Cardiovasc Med 2007; 4: 214–225.

Varret M, Abifadel M, Rabes JP, Boileau C : Genetic heterogeneity of autosomal dominant hypercholesterolemia. Clin Genet 2008; 73: 1–13.

Leigh SE, Foster AH, Whittall RA, Hubbart CS, Humphries SE : Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet 2008; 72 (Pt 4): 485–498.

Usifo E, Leigh SE, Whittall RA et al. Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment. Ann Hum Genet 2012; 76: 387–401.

Liu J, Ahlborn TE, Briggs MR, Kraemer FB : Identification of a novel sterol-independent regulatory element in the human low density lipoprotein receptor promoter. J Biol Chem 2000; 275: 5214–5221.

Smith AJ, Ahmed F, Nair D et al. A functional mutation in the LDLR promoter (-139C>G) in a patient with familial hypercholesterolemia. Eur J Hum Genet 2007; 15: 1186–1189.

Natesampillai S, Fernandez-Zapico ME, Urrutia R, Veldhuis JD : A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function. J Biol Chem 2006; 281: 3040–3047.

Francova H, Trbusek M, Zapletalova P, Kuhrova V : New promoter mutations in the low-density lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype: molecular and functional analysis. J Inherit Metab Dis 2004; 27: 523–528.

Medeiros AM, Alves AC, Francisco V, Bourbon M : Update of the Portuguese Familial Hypercholesterolaemia Study. Atherosclerosis 2010; 212: 553–558.

Taylor A, Wang D, Patel K et al. Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin Genet 2010; 77: 572–580.

Cartharius K, Frech K, Grote K et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005; 21: 2933–2942.

Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E : MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 2003; 31: 3576–3579.

De Castro-Oros I, Pampin S, Bolado-Carrancio A et al. Functional analysis of LDLR promoter and 5' UTR mutations in subjects with clinical diagnosis of familial hypercholesterolemia. Hum Mutat 2011; 32: 868–872.

Yang WS, Nevin DN, Peng R, Brunzell JD, Deeb SS : A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc Natl Acad Sci USA 1995; 92: 4462–4466.

Nakshatri H, Nakshatri P, Currie RA : Interaction of Oct-1 with TFIIB. Implications for a novel response elicited through the proximal octamer site of the lipoprotein lipase promoter. J Biol Chem 1995; 270: 19613–19623.

Li H, Dong B, Park SW, Lee HS, Chen W, Liu J : Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine. J Biol Chem 2009; 284: 28885–28895.

Dhawan P, Chang R, Mehta KD : Identification of essential nucleotides of the FP1 element responsible for enhancement of low density lipoprotein receptor gene transcription. Nucleic Acids Res 1997; 25: 4132–4138.

Scholtz CL, Peeters AV, Hoogendijk CF et al. Mutation -59c—>t in repeat 2 of the LDL receptor promoter: reduction in transcriptional activity and possible allelic interaction in a South African family with familial hypercholesterolaemia. Hum Mol Genet 1999; 8: 2025–2030.

Bodamer OA, Bercovich D, Schlabach M, Ballantyne C, Zoch D, Beaudet AL : Use of denaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia. Clin Chem 2002; 48: 1913–1918.

Lind S, Rystedt E, Eriksson M, Wiklund O, Angelin B, Eggertsen G : Genetic characterization of Swedish patients with familial hypercholesterolemia: a heterogeneous pattern of mutations in the LDL receptor gene. Atherosclerosis 2002; 163: 399–407.

Fouchier SW, Kastelein JJ, Defesche JC : Update of the molecular basis of familial hypercholesterolemia in The Netherlands. Hum Mutat 2005; 26: 550–556.

Peeters AV, Kotze MJ, Scholtz CL et al. A 3-basepair deletion in repeat 1 of the LDL receptor promoter reduces transcriptional activity in a South African Pedi. J Lipid Res 1998; 39: 1021–1024.

Dedoussis GV, Genschel J, Bochow B et al. Molecular characterization of familial hypercholesterolemia in German and Greek patients. Hum Mutat 2004; 23: 285–286.

Francova H, Trbusek M, Zapletalova P, Kuhrova V : New promoter mutations in the low-density lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype: molecular and functional analysis. J Inherit Metab Dis 2004; 27: 523–528.

Day IN, Whittall RA, O'Dell SD et al. Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia. Hum Mutat 1997; 10: 116–127.

Mozas P, Galetto R, Albajar M, Ros E, Pocovi M, Rodriguez-Rey JC : A mutation (-49C>T) in the promoter of the low density lipoprotein receptor gene associated with familial hypercholesterolemia. J Lipid Res 2002; 43: 13–18.

Dedoussis GV, Pitsavos C, Kelberman D et al. FH-Pyrgos: a novel mutation in the promoter (-45delT) of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia. Clin Genet 2003; 64: 414–419.

Sun XM, Neuwirth C, Wade DP, Knight BL, Soutar AK : A mutation (T-45C) in the promoter region of the low-density-lipoprotein (LDL)-receptor gene is associated with a mild clinical phenotype in a patient with heterozygous familial hypercholesterolaemia (FH). Hum Mol Genet 1995; 4: 2125–2129.

Hobbs HH, Brown MS, Goldstein JL : Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992; 1: 445–466.

Koivisto UM, Palvimo JJ, Janne OA, Kontula K : A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sci USA 1994; 91: 10526–10530.

Laurie AD, Scott RS, George PM : Genetic screening of patients with familial hypercholesterolaemia (FH): a New Zealand perspective. Atheroscler Suppl 2004; 5: 13–15.

Mozas P, Castillo S, Tejedor D et al. Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR. Hum Mutat 2004; 24: 187.

Sozen MM, Whittall R, Oner C et al. The molecular basis of familial hypercholesterolaemia in Turkish patients. Atherosclerosis 2005; 180: 63–71.